| Literature DB >> 34950700 |
Haiyan Chen1, Qi Sun2, Cangang Zhang3, Junjun She4, Shuai Cao5, Meng Cao1, Nana Zhang1, Ayarick Vivian Adiila1, Jinjin Zhong1, Chengyun Yao6, Yili Wang1, Hongping Xia2,4, Linhua Lan7.
Abstract
Gastric cancer (GC) is rampant around the world. Most of the GC cases are detected in advanced stages with poor prognosis. The identification of marker genes for early diagnosis is of great significance. Studying the tumor environment is helpful to acknowledge the process of tumorigenesis, development, and metastasis. Twenty-two kinds of immune cells were calculated by CIBERSORT from Gene Expression Omnibus (GEO) database. Subsequently, higher infiltration of macrophages M0 was discovered in GC compared with normal tissues. WGCNA was utilized to construct the network and then identify key modules and genes related to macrophages in TCGA. Finally, 18 hub genes were verified. In the PPI bar chart, the top 3 genes were chosen as hub genes involved in most pathways. On the TIMER and THPA websites, it is verified that the expression levels of CYBB, CD86, and C3AR1 genes in tumor tissues were higher than those in normal tissues. These genes may work as biomarkers or targets for accurate diagnosis and treatment of GC in the future. Our findings may be a new strategy for the treatment of GC.Entities:
Keywords: WGCNA; gastric cancer; hub genes; immune infiltration; macrophage
Year: 2021 PMID: 34950700 PMCID: PMC8688826 DOI: 10.3389/fmolb.2021.756085
Source DB: PubMed Journal: Front Mol Biosci ISSN: 2296-889X
FIGURE 1The flowchart of the data processing. GSE13911 was used to analyze the immune cell profiles by CIBERSORT. Corresponding TCGA gene expression and clinical data were used to find the genes related to tumor-infiltrating macrophages by WGCNA. Through PPI analysis, 3 hub genes were identified. The relationship between hub genes and tumor-infiltrating macrophages was explored by TIMER. The expression of hub genes in tumor and normal tissues was identified in GEPIA. HPA was utilized to verify the expression of hub genes between adjacent non-tumorous tumor and tumor tissues. This result was validated by IHC.
FIGURE 2CIBERSORT algorithm for immune infiltration analysis of GEO data. (A) Relative percent of 22 kinds of immune cells in GEO. (B) A heat map of the cell infiltration data in 69 samples. (C) CorHeatmap of 22 immune cells in normal and tumor tissues. (D) A comparison of normal and tumor tissues. Blue represent normal controls. Red represent tumor group.
FIGURE 3Clinical stage of macrophage in TCGA. (A) Macrophage fraction in the I-IV stage. (B) Macrophage fraction in G1-G3 grade. (C) Macrophage fraction in the T1-T4 stage. (D) Macrophage fraction in N0-N3 stage.
FIGURE 4The determination of soft threshold power. (A) Screening out the samples with outlier expression. (B) By hierarchical clustering, genes were divided into different modules. Different colors equal to different modules. (C) Scale-free fit index analysis of 1–20 soft threshold power (β). The horizontal axis was the soft threshold (power), and the vertical axis was the evaluation parameter of the scale-free network. The higher the value, the more the network conforms to the non-scale feature (non-scale). (D) The average connectivity of soft threshold power was analyzed.
FIGURE 5The identification of key modules and genes. (A) Co-expression gene modules were acquired from a hierarchical cluster dendrogram. (B) Heatmap displays correlations of module eigengenes with macrophages. (C) In the MEpink module, each dot represented a gene. The upper right corner of the scatter plot showed genes under the condition of MM > 0.8 and GS > 0.5. (D) The correlation heat map of 18 genes. (E) Core genes in PPI. (F) Co-expression of key genes and upstream genes.
Functional roles of 18 hub genes.
| No | Gene symbol | Full name | Function |
|---|---|---|---|
| 1 | HAVCR2 | Hepatitis A virus cellular receptor 2 | HAVCR2 is an immune checkpoint and together with other inhibitory receptors including programmed cell death protein 1 and lymphocyte activation gene 3 protein mediates the CD8+ T-cell exhaustion |
| 2 | SLAMF8 | SLAM family member 8 | This gene encodes a member of the CD2 family of cell surface proteins involved in lymphocyte activation. These proteins are characterized by Ig domains |
| 3 | CD300LF | CD300 molecule like family member f | Members of this family are cell surface glycoproteins with a single IgV-like extracellular domain and are involved in the regulation of immune response |
| 4 | CD86 | CD86 molecule | Receptor involved in the costimulatory signal essential for T-lymphocyte proliferation and interleukin-2 production, by binding CD28 or CTLA-4 |
| 5 | SIGLEC7 | Sialic acid-binding Ig like lectin 7 | Putative adhesion molecule that mediates sialic-acid dependent binding to cells. Preferentially binds to alpha-2,3- and alpha-2,6-linked sialic acid |
| 6 | PILRA | Paired immunoglobin like type 2 receptor alpha | PILRA is thought to act as a cellular signaling inhibitory receptor by recruiting cytoplasmic phosphatases like PTPN6/SHP-1 and PTPN11/SHP-2 |
| 7 | CYBB | Cytochrome b-245 beta chain | It is the terminal component of a respiratory chain that transfers single electrons from cytoplasmic NADPH across the plasma membrane to molecular oxygen on the exterior |
| 8 | PLA2G7 | Phospholipase A2 group VII | The protein encoded by this gene is a secreted enzyme that catalyzes the degradation of platelet-activating factor to biologically inactive products |
| 9 | SIGLEC9 | Sialic acid-binding Ig like lectin 9 | Putative adhesion molecule that mediates sialic-acid dependent binding to cells |
| 10 | C3AR1 | Complement C3a receptor 1 | Receptor for the chemotactic and inflammatory peptide anaphylatoxin C3a. This receptor stimulates chemotaxis, granule enzyme release, and superoxide anion production |
| 11 | FCGR1A | Fc fragment of IgG receptor Ia | This gene encodes a protein that plays an important role in the immune response. This protein is a high-affinity Fc-gamma receptor |
| 12 | HK3 | Hexokinase 3 | This gene encodes hexokinase 3. Similar to hexokinases 1 and 2, this allosteric enzyme is inhibited by its product glucose-6-phosphate |
| 13 | LILRB4 | Leukocyte immunoglobulin-like receptor B4 | This gene is a member of the leukocyte immunoglobulin-like receptor family, which is found in a gene cluster at chromosomal region 19q13.4 |
| 14 | CLEC7A | C-type lectin domain containing 7A | This gene is closely linked to other CTL/CTLD superfamily members on chromosome 12p13 in the natural killer gene complex region |
| 15 | FPR3 | Formyl Peptide Receptor 3 | This gene includes G protein-coupled receptor activity and N-formyl peptide receptor activity. An important paralog of this gene is FPR2 |
| 16 | NCF2 | Neutrophil cytosolic factor 2 | This gene encodes neutrophil cytosolic factor 2, the 67-kilodalton cytosolic subunit of the multi-protein NADPH oxidase complex found in neutrophils |
| 17 | IGSF6 | Immunoglobulin Superfamily Member 6 | This gene related to transmembrane signaling receptor activity |
| 18 | GPR141 | G protein-coupled receptor 141 | GPR141 is a member of the rhodopsin family of G protein-coupled receptors (GPRs) |
FIGURE 6IHC of CD86, CYBB, and C3AR1 in GC and normal tissues. (A) The expression level of CD86 in normal and GC tissues. (B) Images of CYBB IHC (Original magnification, × 20). (C) IHC for C3AR1.
FIGURE 7Six kinds of immune cells infiltration situation in TIMER. (A) The effect of CD86, CYBB, C3AR1 expression on six kinds of immune cells. (B) The survival of immune cells. (C) Mutations influence the immune infiltration (*p < 0.05, **p < 0.01, ***p < 0.001).
FIGURE 8Functional enrichment of key genes. (A) The blue module was significantly enriched in GO annotations. (B) The blue module was significantly enriched in KEGG pathways. (C) Filtering the path with ClueGO.
Top 20 GO-Biological Process enrichment analysis of DEGs in GC samples.
| Ontology | Term | Description | Count | p.adjust |
|---|---|---|---|---|
| BP | GO:0045730 | respiratory burst | 4 | 2.42E-05 |
| BP | GO:1903557 | positive regulation of tumor necrosis factor superfamily cytokine production | 4 | 4.15E-04 |
| BP | GO:0042554 | superoxide anion generation | 3 | 1.09E-03 |
| BP | GO:0071675 | regulation of mononuclear cell migration | 3 | 1.60E-03 |
| BP | GO:1903555 | regulation of tumor necrosis factor superfamily cytokine production | 4 | 1.60E-03 |
| BP | GO:0071706 | tumor necrosis factor superfamily cytokine production | 4 | 1.60E-03 |
| BP | GO:0032663 | regulation of interleukin-2 production | 3 | 1.60E-03 |
| BP | GO:0032623 | interleukin-2 production | 3 | 2.12E-03 |
| BP | GO:0042108 | positive regulation of cytokine biosynthetic process | 3 | 2.39E-03 |
| BP | GO:0006801 | superoxide metabolic process | 3 | 2.58E-03 |
| BP | GO:0002479 | antigen processing and presentation of exogenous peptide antigen | 3 | 2.58E-03 |
| BP | GO:0042590 | antigen processing and presentation of exogenous peptide antigen | 3 | 2.58E-03 |
| BP | GO:0002683 | negative regulation of immune system process | 5 | 2.58E-03 |
| BP | GO:0001819 | positive regulation of cytokine production | 5 | 2.58E-03 |
| BP | GO:0002430 | complement receptor-mediated signaling pathway | 2 | 2.58E-03 |
| BP | GO:0045086 | positive regulation of interleukin-2 biosynthetic process | 2 | 2.58E-03 |
| BP | GO:0032760 | positive regulation of tumor necrosis factor production | 3 | 2.58E-03 |
| BP | GO:0051249 | regulation of lymphocyte activation | 5 | 2.58E-03 |
| BP | GO:0071674 | mononuclear cell migration | 3 | 2.73E-03 |
| BP | GO:0002474 | antigen processing and presentation of peptide antigen | 3 | 3.15E-03 |
GO-Cellular Components, GO-Molecular Function, and KEGG pathway enrichment analysis of DEGs in GC samples.
| Ontology | Term | Description | Count | p.adjust |
|---|---|---|---|---|
| CC | GO:0043020 | NADPH oxidase complex | 2 | 3.69E-03 |
| CC | GO:0030667 | secretory granule membrane | 3 | 3.46E-02 |
| CC | GO:0030139 | endocytic vesicle | 3 | 3.46E-02 |
| CC | GO:0035579 | specific granule membrane | 2 | 3.46E-02 |
| CC | GO:1990204 | Oxidoreductase complex | 2 | 4.15E-02 |
| CC | GO:0045335 | phagocytic vesicle | 2 | 4.76E-02 |
| MF | GO:0016175 | superoxide-generating NADPH oxidase activity | 2 | 2.32E-03 |
| MF | GO:0050664 | Oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor | 2 | 2.32E-03 |
| MF | GO:0030246 | Carbohydrate-binding | 4 | 2.32E-03 |
| MF | GO:0042287 | MHC protein binding | 2 | 9.31E-03 |
| MF | GO:0016651 | Oxidoreductase activity, acting on NAD(P)H | 2 | 4.90E-02 |
| MF | GO:0009055 | electron transfer activity | 2 | 4.90E-02 |
| KEGG | hsa04145 | Phagosome | 4 | 1.65E-03 |
| KEGG | hsa05140 | Leishmaniasis | 3 | 2.98E-03 |
| KEGG | hsa05150 |
| 3 | 3.82E-03 |
| KEGG | hsa04380 | Osteoclast differentiation | 3 | 6.69E-03 |